Loading...

Lisbon Addictions 2015

September 23-25, 2015, Lisbon

event logo

1st European Cconference on addictive behaviours and dependencies

sponsor logos

The Lisbon Addictions conference
— a major new event in the addictions calendar

Save the date for Lisbon Addictions 2017:  
24–26 October 2017

Conference newsletter with details on Lisbon Addictions 2017 | Subscribe

Follow us on Twitter

Facebook events page

info@lisbonaddictions.eu

Live

Photo album of 2015 event (restricted to participants)

Lisbon Addictions 2015, 23-25 September 2015

Lisbon Addictions 2015 is now over — thanks to everyone who participated and we look forward to seeing you all at LxAddictions 2017!

Friday, 25 September

Topic of the day – Challenges of addiction in an interconnected world

The final morning of the conference will start with a plenary on this topic. There will then follow paper sessions, symposia and rapid communications focusing on the impact of technology and change, E-health, Internet drug markets, new psychoactive substances and other related themes. The conference closing ceremony will take place just before lunch.

Thursday, 24 September

Topics of the day – Translating research into policy and practice and New frontiers in addiction research

The day will start with a plenary session on the first topic, focusing on best practice, public health policies and behaviour change theories. The delegates will then break into paper sessions, symposia and rapid communication presentations to discuss the topic further.

During the lunch break there will be sponsored sessions by SICAD, CHAFEA, Reitox and the EMCDDA/ECDC.

Afternoon sessions will focus on New frontiers in addiction research, and the day will wrap up with a plenary session on the same topic.

The conference dinner will be held in the evening (prior booking required).

Wednesday, 23 September

Topic of the day – Addiction: a multi-disciplinary perspective

Following the opening ceremony and a plenary session for all delegates there will follow a whole day of events on this topic, with a mix of paper sessions, symposia and rapid communications. They will consider the multi-faceted, highly complex nature of addiction which encompasses a broad range of research disciplines, such as public health, sociology, medicine, law, criminology, political science and economics.

During the lunch break there will be sponsored sessions by the EMCDDA, CHAFEA, NIDA, UNICRI, WHO and GILEAD SCIENCES INC.

At 6.30 pm, the EMCDDA will hold its Scientific Paper award ceremony, during the opening cocktail.

About the conference

  • 16 keynote speeches
  • more than 200 oral presentations
  • around 140 rapid communications and
  • a week-long array of satellite meetings, side-events and sponsored sessions

Over 600 participants — researchers, practitioners and policy experts from 58 countries and a range of specialist areas — will attend the First European conference on addictive behaviours and dependencies to be held in Lisbon on 23–25 September.

Programme

Press release

Follow our Twitter account and make use of our hashtag #LXAddictions15 to share with the world what is going on at Lisbon Addictions 2015. We will promote your tweets and posts.

The conference will start on the morning of September 23.

Picture of the Lisbon Addictions 2015 venue
Venue: FIL Meeting Centre - Parque das Nações
Address: Rua do Bojador - Parque das Nações | 1998-010 Lisbon – Portugal
(GPS 38.769446, -9.092897) | Google Maps

About Lisbon Addictions 2015

The First European conference on addictive behaviours and dependencies will be held in Lisbon on 23–25 September 2015. Various satellite meetings will take place on 21–22 September (details can be found here).

This will be a comprehensive and multi-disciplinary event, showcasing leading European addiction research in the specialist areas of illicit drugs, alcohol, tobacco, gambling and other addictive behaviours. It will address new challenges and cover developing fields such as new psychoactive substances, online sales and gambling, cannabis legalisation and alcohol pricing.

This conference will provide a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines to discuss latest findings on the prevention, treatment and control of addiction. It is the ideal venue to forge collaborative partnerships and explore funding opportunities.

This conference is jointly organised by the Portuguese General Directorate for Intervention on Addictive Behaviours and Dependencies (Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências — SICAD), the journal Addiction, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the International Society of Addiction Journal Editors (ISAJE). It will take place at the FIL Expo meeting centre in the beautiful city of Lisbon.

Download the conference flyer here.

Call for abstracts — CLOSED

Keynote speakers

Guidelines for speakers and session chairs.

Peter Anderson

Professor, Substance Use, Policy and Practice, Institute of Health and Society, Newcastle University, England
 

 

Peter Anderson

Newcastle University, UK

Thomas F. Babor

Professor and Chairman, Departement of Community Medicine & Health Care, University of Connecticut School of Medicine
 

 

Thomas F. Babor

University of Connecticut, USA

Linda Bauld

Professor of Health Policy and Director of the Institute for Social Marketing, University of Stirling and the UK Centre for Tobacco and Alcohol Studies. Chair in Behavioural Research for Cancer Prevention, Cancer Research UK

 

Linda Bauld

University of Stirling, UK

Anne Line Bretteville-Jensen

Research Director, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway

 

Anne Line Bretteville-Jensen

Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway

Gerhard Bühringer

Chair of Addiction Research, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany

 

Gerhard Bühringer

Technische Universität Dresden, Germany

Félix Carvalho

Full Professor of Toxicology at the Faculty of Pharmacy, University of Porto and Secretary-General of EUROTOX
 

 

Félix Carvalho

University of Porto, Portugal

Brice de Ruyver

Full Professor criminal law and criminology, Director Institute for International Research on Criminal Policy, Ghent University, Belgium

 

Brice de Ruyver

Ghent University, Belgium

Hein de Vries

Professor in Health Communication, Department of Health Promotion, School for Public Health and Primary Care, Maastricht University, The Netherlands

 

Hein de Vries

Maastricht University, The Netherlands

Marina Davoli

Head, Department of Epidemiology, National Agency for Health Services, Italy

 

Marina Davoli

National Agency for Health Services, Italy

Gabriele Fischer

Medical Director of the Addiction Clinic at the Medical University Vienna, Austria

Gabriele Fischer

Medical University, Vienna, Austria

Antoni Gual

Director of the Addictions Unit, Psychiatry Department, Institute of Neuroscience, Hospital Clínic, Barcelona

 

Antoni Gual

Hospital Clínic, Barcelona, Spain

Keith Humphreys

Professor, Stanford School of Medicine

 

Keith Humphreys

Stanford School of Medicine, USA

Henrique Lopes

President of the Ibero-latin-american Scientific Society for Gambling Research, Chair of CEIA research center
 

 

Henrique Lopes

Public Healthcare Unit of Catholic University, Portugal

Susana Jiménez-Murcia

Head of Pathological Gambling Unit, University Hospital of Bellvitge-IDIBELL
Associate Professor, School of Medicine, University of Barcelona

 

Susana Jiménez-Murcia

University Hospital of Bellvitge, Spain

Pia Mäkelä

Senior Researcher and Head of Unit, National Institute for Health and Welfare, Helsinki, Finland

 

Pia Mäkelä

National Institute for Health and Welfare, Helsinki, Finland

Robert West

Professor of Health Psychology, University College London, UK

 

Robert West

University College London, UK

Marina Picciotto

Professor of Neurobiology and Pharmacology, Yale University School of Medicine, New Haven, USA

 

Marina Picciotto

Yale University School of Medicine, USA

Margriet van Laar

Head of the Department Drug Monitoring, Trimbos Institute, The Netherlands

 

Margriet van Laar

Trimbos Institute, The Netherlands

Programme

programme thumbnail
Download the full conference programme (PDF)

Download the programme of sponsored sessions (PDF)

Conference format

The conference is organised around four general themes:

  • Addictions: a multi-disciplinary perspective
  • Translating research into policy and practice
  • New frontiers in addiction research
  • Challenges of addiction in an interconnected world

Together with papers and rapid communications, each theme will be represented by one plenary session (keynote speech or roundtable) that will be designed for a multi-disciplinary audience on a topical issue. In addition, open paper sessions will accommodate papers that do not necessarily fit within these four themes.

To promote networking, conference rooms will be available for group meetings and small satellite meetings. If interested please contact us at: info@lisbonaddictions.eu

Presentations

A selection of presentations from the conference can be found below. In case you were a speaker at LxAddictions and your presentation is not yet uploaded, please contact info@lisbonaddictions.eu

Use the buttons to navigate between days.

Day 1 (23.09.2015) presentations
Day Type of session Title of session Chair Name of presenter Title of presentation
23.09.2015 Plenary session 1 Addictions: a multi-disciplinary perspective Anne Line Bretteville-Jensen, Norway  Robert West,
United Kingdom
Have we got the balance right? Return on investment from brain, behavioural and social sciences in the field of addiction?
23.09.2015 Plenary session 1 Addictions: a multi-disciplinary perspective Anne Line Bretteville-Jensen, Norway Marina Picciotto, USA Have we got the balance right? Return on investment from brain, behavioural and social sciences in the field of addiction? (response)
23.09.2015 Plenary session 1 Addictions: a multi-disciplinary perspective Anne Line Bretteville-Jensen, Norway Mark Kleiman, USA Do we need treatment as a first response to addiction problems?
23.09.2015 Plenary session 1 Addictions: a multi-disciplinary perspective Anne Line Bretteville-Jensen, Norway Gabriele Fischer, Austria Do we need treatment as a first response to addiction problems? (response)
23.09.2015 Paper session 1 Perspectives on addictions: Environment and context Michael Farrell, Ireland Robin Room, Australia Addiction as failure in social roles
23.09.2015 Paper session 1 Perspectives on addictions: Environment and context Michael Farrell, Ireland Marja Holmila, Finland Substance abuse and intergenerational transmission of inequity in health: possibilities of preventive action
23.09.2015 Paper session 1 Perspectives on addictions: Environment and context Michael Farrell, Ireland Ingunn Olea Lund, Norway How problematic do victims of harm from others’ drinking and people in general perceive such harm?
23.09.2015 Paper session 1 Perspectives on addictions: Environment and context Michael Farrell, Ireland Peggy van der Pol, The Netherlands Cannabis potency, dosing and smoking behaviour
23.09.2015 Paper session 1 Perspectives on addictions: Environment and context Michael Farrell, Ireland Wouter Vanderplasschen, Belgium Implementation of minimal quality standards in drug demand reduction in Belgium: a bottom-up consensus building process involving all relevant stakeholders (COMIQS.BE)
23.09.2015 Paper session 2 In the spotlight: gambling François Beck, France Sylvia Kairouz, Canada A multilevel analysis of contextual gambling expenditures among undergraduates
23.09.2015 Paper session 2 In the spotlight: gambling François Beck, France Filipa Calado, United Kingdom ‘You bet, but I don't!’ A preliminary study about gaming and gambling perceptions and behaviours among Portuguese youth
 23.09.2015 Paper session 2 In the spotlight: gambling François Beck, France Natale Canale, Italy ‘I am becoming more and more like my eldest brother!’ The attenuating effect of parental knowledge on the relationship between older siblings and adolescent problem gambling
23.09.2015 Paper session 2 In the spotlight: gambling François Beck, France Jean-Michel Costes, France Patterns, risk factors and gambling related problems in France: results from the 2014 gambling national survey
23.09.2015 Paper session 2 In the spotlight: gambling François Beck, France Sabrina Molinaro, Italy Country — and individual — level determinants of probable problematic gambling in adolescence: a multi-level cross-national comparison
23.09.2015 Paper session 3 In the spotlight: smoking Ann McNeil, United Kingdom Ron Borland, Australia Reconceptualising addiction: insights from research on smoking cessation
23.09.2015 Paper session 3 In the spotlight: smoking Ann McNeil, United Kingdom Donna Pettey, Canada Efficacy of smoking cessation treatment interventions for individuals with severe mental illness: a pilot randomised controlled clinical trial
23.09.2015 Paper session 3 In the spotlight: smoking Ann McNeil, United Kingdom Leonie S. Brose, United Kingdom Perceived relative harm of electronic cigarettes (e-cigarettes) and attitudes towards their availability, advertising and use: a longitudinal survey
23.09.2015 Paper session 3 In the spotlight: smoking Ann McNeil, United Kingdom Gerhard Gmel, Switzerland The longitudinal association between e-cigarette use and burned cigarette use — is vaping an effective means of smoking reduction or cessation?
23.09.2015 Paper session 3 In the spotlight: smoking Ann McNeil, United Kingdom Marina Topuridze presented by Nino Maglakelidze, Georgia Prevalence and correlates of tobacco use, uptake of cessation resources, and intervention by providers
23.09.2015 Paper session 4 Measuring addiction: definitions and tools John Marsden, United Kingdom
 
Ludwig Kraus, Germany Prevalence of substance use disorder. A question of definition?
23.09.2015 Paper session 4 Measuring addiction: definitions and tools John Marsden, United Kingdom
 
Patricia Gómez, Spain Is the CRAFFT a good tool to screen for alcohol abuse in the school context?
23.09.2015 Paper session 4 Measuring addiction: definitions and tools John Marsden, United Kingdom
 
Antonio Rial, presented by Manuel Araujo, Spain Psychometric properties of the self-administered AUDIT in Spanish adolescents
23.09.2015 Paper session 4 Measuring addiction: definitions and tools John Marsden, United Kingdom
 
Andrew Jones, United Kingdom The impact of payment by results pilots on recovery outcomes in England.
23.09.2015 Paper session 4 Measuring addiction: definitions and tools John Marsden, United Kingdom
 
James R. McKay, USA Effect of patient choice in an adaptive sequential randomisation trial of treatment for alcohol and cocaine dependence
23.09.2015 Symposium session A Cannabis addiction: what is the problem? Michael Bloomfield and Valerie Curran, United Kingdom Wayne Hall, Australia The potential harms of cannabis addiction
23.09.2015 Symposium session A Cannabis addiction: what is the problem? Michael Bloomfield and Valerie Curran, United Kingdom Paul Griffiths, EMCDDA Cannabis addiction: does epidemiology vary with a country’s drug policy?
23.09.2015 Symposium session A Cannabis addiction: what is the problem? Michael Bloomfield and Valerie Curran, United Kingdom Michael Bloomfield, United Kingdom Neuropharmacology of cannabis addiction: evidence from preclinical and clinical research
23.09.2015 Symposium session A Cannabis addiction: what is the problem? Michael Bloomfield and Valerie Curran, United Kingdom Valerie Curran, United Kingdom Purple haze, Northern lights, skunk and sinsemilla: how does the type of cannabis used influence psychological aspects dependence?
23.09.2015 Symposium session A Cannabis addiction: what is the problem? Michael Bloomfield and Valerie Curran, United Kingdom Tom Freeman, United Kingdom How can we optimise treatment of people who are cannabis dependent?
23.09.2015 Symposium session B Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Toni Gual, Spain Introduction to the LEADER project
23.09.2015 Symposium session B  Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Pablo Barrio, Spain Systematic review on social costs analysis
23.09.2015 Symposium session B  Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Vincenzo Vella, Spain Systematic review on guidance documents
23.09.2015 Symposium session B  Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Zofia Mielecka-Kubien, Poland Guidance for analysis of social costs
23.09.2015 Symposium session B  Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Paul Lemmens, Belgium and Gera Nagelhout, The Netherlands Key messages from the LEADER work on the impact of economic recession
23.09.2015 Symposium session B Costs and crises: the LEADER project — examining the
avoidable burden of drug use in the current economic climate
Toni Gual, Spain Jillian Reynolds, Spain Take home messages
23.09.2015 Paper session 5 Perspectives on addictions: criminal justice Liesbeth Vandam, EMCDDA Charlotte Colman, Belgium Recovery came first’. Conversations about hope and chances on desistance and recovery in the criminal and drug-using careers of drug-using offenders
23.09.2015 Paper session 5 Perspectives on addictions: criminal justice Liesbeth Vandam, EMCDDA Matthias Pierce, United Kingdom Effectiveness of treatment for substance misuse in reducing offending and mortality, findings from a large linked dataset
23.09.2015 Paper session 5 Perspectives on addictions: criminal justice Liesbeth Vandam, EMCDDA Anália Torres, presented by Rita Veloso, Portugal Drugs and Prisons in Portugal: a survey overview from 2001, 2007 and 2014
23.09.2015 Paper session 5 Perspectives on addictions: criminal justice Liesbeth Vandam, EMCDDA Carla Rossi, Italy Comparison and evaluation of repressive aspects of Italian and Portuguese drug laws and policies using new indicators of criminal unintended consequences
23.09.2015 Paper session 5 Perspectives on addictions: criminal justice Liesbeth Vandam, EMCDDA Brendan Hughes, EMCDDA Drug trafficking penalties in the Member States of the European Union
23.09.2015 Paper session 6 Measuring addictions: costs and benefits Jürgen Rehm, Germany Petra S. Meier, United Kingdom Conclusions from seven years of modelling alcohol policies
23.09.2015 Paper session 6 Measuring addictions: costs and benefits Jürgen Rehm, Germany Ricardo Gonçalves, Portugal Empirical estimation of drug treatment costs in Portugal
23.09.2015 Paper session 6 Measuring addictions: costs and benefits Jürgen Rehm, Germany Julie Brummer, WHO-Regional Office for Europe Construction of a composite indicator to measure the completeness of national alcohol strategies
23.09.2015 Paper session 6 Measuring addictions: costs and benefits Jürgen Rehm, Germany Delfine Lievens, Belgium A methodology for an EU cross-country comparison? Public expenditure for drug treatment in hospitals
23.09.2015 Paper session 6 Measuring addictions: costs and benefits

Jürgen Rehm, Germany

Amy O'Donnell, United Kingdom Measuring the impact of financial incentives on alcohol screening and brief intervention implementation in English primary health care between 2008 and 2014: a mixed-methods investigation
23.09.2015 Paper session 7 Treating addictions: systems and choices Eilish Gilvarry, United Kingdom Gabriele Fischer, Austria Limitations to participation in opioid maintenance treatment in Europe: a structured analysis of patient and user characteristics
23.09.2015 Paper session 7 Treating addictions: systems and choices Eilish Gilvarry, United Kingdom Marie-Claire Lambrechts, Belgium What factors determine the approach of substance abuse of employees by occupational physicians? An online survey based on the I-Change Model
23.09.2015 Paper session 7 Treating addictions: systems and choices Eilish Gilvarry, United Kingdom Jan Klimas, Canada Diversity of training healthcare providers in addiction medicine
23.09.2015 Paper session 7 Treating addictions: systems and choices Eilish Gilvarry, United Kingdom Bernd Schulte, Germany Bridging the evidence to practice gap for screening and brief alcohol interventions in primary health care and beyond: findings from the European BISTAIRS project
23.09.2015 Paper session 7 Treating addictions: systems and choices Eilish Gilvarry, United Kingdom Helene Paus Aasen, Norway Anabolic androgenic steroid dependence and accessible treatment in the addiction health care system — a case policy study
23.09.2015 Paper session 8 Treating addictions: cognition and process Lars Møller, WHO-Regional Office for Europe Reinout W. Wiers, The Netherlands Assessing and changing implicit cognitive processes in addiction
23.09.2015 Paper session 8 Treating addictions: cognition and process Lars Møller, WHO-Regional Office for Europe Jamie Smith-Spark, United Kingdom Executive functions as a mediator of prospective memory performance after a moderate dose of alcohol
23.09.2015 Paper session 8 Treating addictions: cognition and process Lars Møller, WHO-Regional Office for Europe Elizabeth de Sousa Fernandes Perna, The Netherlands Brain reactivity to alcohol and cannabis marketing cues during abstinence and intoxication
23.09.2015 Paper session 8 Treating addictions: cognition and process Lars Møller, WHO-Regional Office for Europe William Crano, USA Mediated mass media effects in cannabis prevention
23.09.2015 Paper session 8 Treating addictions: cognition and process Lars Møller, WHO-Regional Office for Europe Pedro Gamito, Portugal mHealth: new approaches for cognitive stimulation of patients with Alcohol Dependence Syndrome
23.09.2015 Paper session 9 Perspectives on addictions: targeting diversity Catherine Comiskey, Ireland Emanuela Colasante, presented by Sabrina Molinaro, Italy Effect of use and poly-use of drugs on health evaluated through new indicators: trend of harmful use among the general population
23.09.2015 Paper session 9 Perspectives on addictions: targeting diversity Catherine Comiskey, Ireland Katherine I. Morley, United Kingdom Prescription opioid access and misuse amongst users from the USA, United Kingdom, Australia, and New Zealand: results from the 2015 Global Drug Survey
23.09.2015 Paper session 9 Perspectives on addictions: targeting diversity Catherine Comiskey, Ireland Barbara Braun, presented by Hanna Brand, Germany Older adults with alcohol use disorder in the German addiction care system: characterisation and specific needs
23.09.2015 Paper session 9 Perspectives on addictions: targeting diversity Catherine Comiskey, Ireland Karoliina Karjalainen, Finland The misuse of psychoactive prescription drugs among Finnish adult population
23.09.2015 Paper session 9 Perspectives on addictions: targeting diversity Catherine Comiskey, Ireland Casimiro Balsa, Portugal Cohort effect in the General Population Surveys and the reliability and validity of the results on the prevalences of drug use in Portugal
23.09.2015 Symposium session C Addiction and the family Michael Klein, Germany Diana Moesgen, Germany Children and spouses of substance abusers — stress, strain, and interventions
23.09.2015 Symposium session C Addiction and the family Michael Klein, Germany Janina Dyba, Germany Crystal meth and the family — an analysis of the living circumstances and needs of help of affected children
23.09.2015 Symposium session C Addiction and the family Michael Klein, Germany Kenneth Leonard, USA The influence of partner responsiveness and negative exchanges on episodic heavy drinking and alcohol problems over the first nine years of marriage
23.09.2015 Symposium session C Addiction and the family Michael Klein, Germany Peer van der Kreeft, Belgium Parent runner up to Google: results of the Infoscan survey to information search behaviour in children, teenagers and youngsters
23.09.2015 Symposium session D Tools for a comprehensive approach to safer and healthier recreational settings Fernando Mendes, Portugal Irma Brito, Portugal Vulnerability assessment in the recreational context
23.09.2015 Symposium session D Tools for a comprehensive approach to safer and healthier recreational settings Fernando Mendes, Portugal Paulo Anjos, Portugal Outreach work teams
23.09.2015 Symposium session D Tools for a comprehensive approach to safer and healthier recreational settings Fernando Mendes, Portugal Maria do Rosario Mendes, Portugal Staff training in recreational nightlife
23.09.2015 Symposium session D Tools for a comprehensive approach to safer and healthier recreational settings Fernando Mendes, Portugal   Open discussion of the findings of the Club Health project and their relevance and implications
23.09.2015 Symposium session E Ownership of addiction: stakeholders over time and place Henk Garretsen, The Netherlands Matilda Hellman, Finland What can addiction policy analysis gain from a social epistemological approach?
23.09.2015 Symposium session E Ownership of addiction: stakeholders over time and place Henk Garretsen, The Netherlands Franca Beccaria, Italy Windows of opportunities: the role of external stakeholders in drug regulation in four European countries at the turn of the 21st century
23.09.2015 Symposium session E Ownership of addiction: stakeholders over time and place Henk Garretsen, The Netherlands Bagga Bjerge, Denmark Medicalisation or de-medicalisation? A comparative analysis of medical professionals as stakeholders in policy processes and in treatment practices in Denmark and the United Kingdom
23.09.2015 Symposium session E Ownership of addiction: stakeholders over time and place Henk Garretsen, The Netherlands Jacek Moskalewicz, Poland Images and policy in Poland: from depenalisation of drug possession to its criminalisation
23.09.2015 Symposium session E Ownership of addiction: stakeholders over time and place Henk Garretsen, The Netherlands Rachel Herring, United Kingdom The emergence of the Alcohol Health Alliance as public health stakeholders
Day 2 (24.09.2015) presentations
Day Type of session Title of session Chair Name of presenter Title of presentation
24.09.2015 Plenary session 2 Translating research into policy and practice Margriet Van Laar, The Netherlands Linda Bauld, United Kingdom Addictions research and influencing policy: if at first you don't succeed, try try (and try) again
24.09.2015 Plenary session 2 Translating research into policy and practice Margriet Van Laar, The Netherlands Felix Carvalho, Portugal Translating research on new psychoactive substances into policy and practice
24.09.2015 Plenary session 2 Translating research into policy and practice Margriet Van Laar, The Netherlands Keith Humphreys, USA Science and recent addiction-related health care policy in the United States
24.09.2015 Plenary session 2 Translating research into policy and practice Margriet Van Laar, The Netherlands Marina Davoli, Italy Sitting on both sides of the science-policy table. What does each side need from the other and why do they sometimes not get it?
24.09.2015 Plenary session 3 New frontiers in addiction research Henrique Lopes, Portugal Pia Mäkelä, Finland Alcohol research and policy: joining the dots
24.09.2015 Plenary session 3 New frontiers in addiction research Henrique Lopes, Portugal Gerhard Bühringer, Germany Behavioural addictions: the lack of an “enough” button for pleasurable actions?
24.09.2015 Plenary session 3 New frontiers in addiction research Henrique Lopes, Portugal Thomas Babor, USA Infrastructure in Addiction Science: the emergence of an interdisciplinary field and its implications for public health policy
24.09.2015 Plenary session 3 New frontiers in addiction research Henrique Lopes, Portugal Susana Jiménez Murcia, Spain Gambling and age: a complex relationship throughout life
24.09.2015 Paper session 10 New opportunities for harm
reduction: behaviours
Franz Trautmann, The Netherlands Marie Jauffret-Roustide, France Crack use and lesions due to glass pipes: a bridge for HCV transmission — results from the ANRS Crack Intervention Trial
24.09.2015 Paper session 10 New opportunities for harm
reduction: behaviours
Franz Trautmann, The Netherlands Ana Gallegos, EMCDDA Recent developments in the detection of harms arising from the use of synthetic cathinones in Europe
24.09.2015 Paper session 10 New opportunities for harm
reduction: behaviours
Franz Trautmann, The Netherlands Louis Favril, Belgium Identifying local harm reduction priorities: involving drugs users and professionals
24.09.2015 Paper session 10 New opportunities for harm
reduction: behaviours
Franz Trautmann, The Netherlands Américo Nave, Portugal Innovative response through a Housing First programme for illicit and licit drug consumers, homeless, based on a qualitative, descriptive and exploratory observational methods
24.09.2015 Paper session 10 New opportunities for harm
reduction: behaviours
Franz Trautmann, The Netherlands Basak Tas, United Kingdom Unsupervised heroin prescribing and deaths in the ‘British System’ of the 60s and 70s: a systematic literature review
24.09.2015 Paper session 11 New opportunities for harm
reduction: infectious diseases
Richard Pates, United Kingdom Matthew Hickman, United Kingdom How should scale up of HCV antiviral treatment be prioritised? A cost-effectiveness analysis including individual and population prevention benefits
24.09.2015 Paper session 11 New opportunities for harm
reduction: infectious diseases
Richard Pates, United Kingdom Anastasios Fotiou, Greece, presented by Clive Richardson, Greece HCV/HIV coinfection among people who inject drugs entering opioid substitution treatment in Greece: prevalence and correlates
24.09.2015 Paper session 11 New opportunities for harm
reduction: infectious diseases
Richard Pates, United Kingdom Janusz Sieroslawski, Poland Estimation of prevalence of HCV among IDUs in Poland and identification of risk factors
24.09.2015 Paper session 11 New opportunities for harm
reduction: infectious diseases
Richard Pates, United Kingdom Anne Batisse, France Sexuality of substance-using men who have sex with men (SUMSM)
24.09.2015 Paper session 11 New opportunities for harm
reduction: infectious diseases
Richard Pates, United Kingdom Filomena Aguiar, Portugal Implications and impact of socio professional reintegration programmes for HIV positive and former drug addicts: the case of Maggie
24.09.2015 Paper session 12 Treating addictions: new insights
for therapy
Dagmar Hedrich, EMCDDA Catherine M. Comiskey, Ireland Hidden harms and benefits: the impact of partners, parenthood and childcare on drug treatment outcomes
24.09.2015 Paper session 12 Treating addictions: new insights
for therapy
Dagmar Hedrich, EMCDDA Sarah Elison, United Kingdom Initial findings from a mixed-methods feasibility and effectiveness evaluation of the ‘Breaking Free Health & Justice’ treatment and recovery programme for substance misuse in prison settings
24.09.2015 Paper session 12 Treating addictions: new insights
for therapy
Dagmar Hedrich, EMCDDA Nidia Rosa, Portugal Alcohol brief intervention in patients in methadone maintenance programmes: a pre-experimental study
24.09.2015 Paper session 12 Treating addictions: new insights
for therapy
Dagmar Hedrich, EMCDDA John Strang, United Kingdom Randomised comparison of a novel buprenorphine oral lyophilisate versus existing buprenorphine sublingual tablets in opioid-dependent patients: a ‘first-in-patient’ Phase II, safety study
24.09.2015 Paper session 12 Treating addictions: new insights
for therapy
Dagmar Hedrich, EMCDDA Maria Diniz, Portugal Addictive behaviour and dependence. Is short in care treatment effective?
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Lars Møller, WHO-Regional Office for Europe Prevention of overdose deaths in the criminal justice system
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Felice Nava, Italy The misuse of opiate substitution therapy: an obstacle for the diffusion of best practices in prisons
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Soraia Teles, Portugal Preventing avoidable deaths: a narrative review and recommendations on opioid overdose
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Rebecca McDonald, United Kingdom Does take-home naloxone fulfill the Bradford Hill criteria for effectiveness? A systematic review
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Shane Darke, Australia The health consequences of injecting tablet preparations: foreign body pulmonary embolisation and pulmonary hypertension amongst deceased injecting drug users
24.09.2015 Paper session 13 In the spotlight: drug-related deaths Jan Malinowski, Pompidou Group Serena Luchenski, United Kingdom Peer engagement in harm reduction services and strategies in British Columbia, Canada: a policy case study
24.09.2015 Paper session 14 Prevention: theory and evidence Rita Notarandrea, Canada Stephane Legleye, presented by François Beck, France Educational inequalities in experimentation and transition to daily cannabis use: 50 years of retrospective cohort and gender analysis in France
24.09.2015 Paper session 14 Prevention: theory and evidence Rita Notarandrea, Canada Anneke Bühler, presented by Johannes Thrul, USA What works in substance abuse prevention? An update based on 62 international reviews of effectiveness
24.09.2015 Paper session 14 Prevention: theory and evidence Rita Notarandrea, Canada Zili Sloboda, USA The Universal Prevention Curriculum Series
24.09.2015 Paper session 14 Prevention: theory and evidence Rita Notarandrea, Canada Fabrizio Faggiano, Italy For a European system of approval of prevention intervention for substance abuse and problem behaviours
24.09.2015 Paper session 14 Prevention: theory and evidence Rita Notarandrea, Canada Marica Ferri, EMCDDA Knowledge exchange and evidence-base for decision-making: can promptness and accuracy go together?
24.09.2015 Paper session 15 Perspectives on addictions: shaping policy Catherine Moury, Portugal David Miller, United Kingdom Think tanks and addictions in the EU — a network study
24.09.2015 Paper session 15 Perspectives on addictions: shaping policy Catherine Moury, Portugal Johan Edman, Sweden The ideological drug problem: Sweden 1960–2015
24.09.2015 Paper session 15 Perspectives on addictions: shaping policy Catherine Moury, Portugal Hilson Cunha-Filho, Portugal Case study about the development and implementation of alcohol policies in Portugal (2000-2012)
24.09.2015 Paper session 15 Perspectives on addictions: shaping policy Catherine Moury, Portugal Annette Dale-Perera, United Kingdom Political influence on the treatment of heroin users in times of austerity: a recipe for recovery, revolution, re-integration or relapse.
24.09.2015 Paper session 15 Perspectives on addictions: shaping policy Catherine Moury, Portugal Katalin Felvinczi, Hungary To get a better understanding of the "Janus face" of social control theories — through the social construct of drug use as an example
24.09.2015 Symposium session F Drug users in prison: interventions to reduce harm and enable recovery Charlie Lloyd, United Kingdom Linda Montanari, EMCDDA Substance use and specific health needs of drug users inside European prisons: what do we know?
24.09.2015 Symposium session F Drug users in prison: interventions to reduce harm and enable recovery Charlie Lloyd, United Kingdom Heino Stöver, Germany Global overview of the transfer of harm reduction into prisons
24.09.2015 Symposium session F Drug users in prison: interventions to reduce harm and enable recovery Charlie Lloyd, United Kingdom Heike Zurhold, Germany What works for reintegration after prison release: findings from a European study
24.09.2015 Symposium session F Drug users in prison: interventions to reduce harm and enable recovery Charlie Lloyd, United Kingdom Sharon Grace, United Kingdom Prison based drug treatment for women: offender's perspectives on Drug Recovery Wings
24.09.2015 Symposium session G Neuro-cognitive predictors of alcohol use: from
fundamental research to the development of interventions
Helle Larsen, The Netherlands Thomas Pronk, The Netherlands Associations between alcohol-related cognitions and alcohol use with a cultural perspective
24.09.2015 Symposium session G Neuro-cognitive predictors of alcohol use: from
fundamental research to the development of interventions
Helle Larsen, The Netherlands Margot Peeters, The Netherlands Findings from a longitudinal study in adolescents
24.09.2015 Symposium session G Neuro-cognitive predictors of alcohol use: from
fundamental research to the development of interventions
Helle Larsen, The Netherlands Kyriaki Nikolaous, United Kingdom Emergence of biased approach action tendencies to alcohol-related stimuli, and their effects on future drinking: Preliminary analyses of behavioural data from the IMAGEN consortium study
24.09.2015 Symposium session G Neuro-cognitive predictors of alcohol use: from fundamental research to the development of interventions Helle Larsen, The Netherlands Reinout Wiers, The Netherlands Conclusions with focus on future directions
24.09.2015 Paper session 16 Frontiers: developments in
basic research
Manuela Grazina, Portugal Ana Paula Silva, Portugal Methamphetamine self-administration leads to bloodbrain barrier dysfunction: an animal study
24.09.2015 Paper session 16 Frontiers: developments in
basic research
Manuela Grazina, Portugal Teresa Summavielle, Portugal Methamphetamine-induced changes in hippocampal neurons morphology is mediated by Rac1 activation
24.09.2015 Paper session 16 Frontiers: developments in
basic research
Manuela Grazina, Portugal Anja Kräplin, Germany Dysfunctions of cognitive control in addiction: Advances and needs in current research
24.09.2015 Paper session 16 Frontiers: developments in
basic research
Manuela Grazina, Portugal Wai Kwong Tang, China Brain Damage in Ketamine Abusers
24.09.2015 Paper session 17 Frontiers: dynamics and change Maria Renström, WHO Martta Forsell, Finland Increase of opioid use in Finland — when is there enough key indicator data to state a trend?
24.09.2015 Paper session 17 Frontiers: dynamics and change Maria Renström, WHO Serena Luchenski, United Kingdom Protective factors associated with cessation of injecting drug use among a Canadian cohort of people who inject drugs
24.09.2015 Paper session 17 Frontiers: dynamics and change Maria Renström, WHO Ellen J. Amundsen, Norway Drug-induced causes of death comprised three groups: persons with very low socioeconomic status, disabled, and persons on the edge of the workforce. A register linkage study
24.09.2015 Paper session 17 Frontiers: dynamics and change Maria Renström, WHO Ana Martins, Portugal Substance use among men who have sex with men in Portugal: a comparison between migrants and non-migrants in the European MSM Internet Survey (EMIS)
24.09.2015 Paper session 17 Frontiers: dynamics and change Maria Renström, WHO Julian Strizek, Austria The European alcopops boom in hindsight: what’s left and what can be learned?
24.09.2015 Paper session 18 Frontiers: addressing complexity Kim Bloomfield, Denmark Dike Van de Mheen, Netherlands Substance use among Dutch homeless people, a follow-up study: prevalence, pattern and housing status
24.09.2015 Paper session 18 Frontiers: addressing complexity Kim Bloomfield, Denmark Hanna Brand, Germany Psychiatric co-morbidity in substance abuse treatment: analysing the current health care situation
24.09.2015 Paper session 18 Frontiers: addressing complexity Kim Bloomfield, Denmark Henning Petersen, Norway Searching for sobriety: a qualitative study of how persons with severe mental illness experience abstaining from substance use
24.09.2015 Paper session 18 Frontiers: addressing complexity Kim Bloomfield, Denmark Michael P. Schaub, Switzerland Treating tobacco dependence and cannabis misuse at the same time — feasibility of a group cessation programme
24.09.2015 Paper session 18 Frontiers: addressing complexity Kim Bloomfield, Denmark Nerilee Hing, Australia How is problem gambling stigmatised? Insights from a mixed-method study of public and self-stigma associated with problem gambling
24.09.2015 Paper session 19 Frontiers: methods and analysis I Wayne Hall, Australia Thomas Nefau, France Used syringes analysis: a new approach to better-know the injected drug uses and users
24.09.2015 Paper session 19 Frontiers: methods and analysis I Wayne Hall, Australia Sara Castiglioni, Italy Wastewater-based epidemiology as a novel tool to evaluate illicit drugs, alcohol and tobacco use in a population
24.09.2015 Paper session 19 Frontiers: methods and analysis I Wayne Hall, Australia Clive Richardson, Greece Estimating the number of older high-risk drug users in Greece
24.09.2015 Paper session 19 Frontiers: methods and analysis I Wayne Hall, Australia Martin Busch, Austria Drug situation in Austria — continuity and change: benefits of cross indicator analysis
24.09.2015 Paper session 19

Frontiers: methods and analysis I

Wayne Hall, Australia Ines Kvaternik, Slovenia Systematic review of the early-warning system on NPS in Slovenia
24.09.2015 Paper session 20 Frontiers: methods and analysis II Steve Gust, NIDA Jozef Sidlo, Slovakia Ten years of monitoring of drug-related deaths in Slovakia
24.09.2015 Paper session 20 Frontiers: methods and analysis II Steve Gust, NIDA Amanda Roxburgh, Australia The changing nature of opioid overdose deaths in Australia
24.09.2015 Paper session 20 Frontiers: methods and analysis II Steve Gust, NIDA Nicole Boffin, Belgium General practice patients treated for substance use problems. A cross-national surveillance study
24.09.2015 Paper session 20 Frontiers: methods and analysis II Steve Gust, NIDA Edimansyah Abdin, Singapore Does problem gambling have a dimensional latent structure? A taxometric analysis
24.09.2015 Paper session 20 Frontiers: methods and analysis II Steve Gust, NIDA Thomas Solgård Svendsen, Norway High demand: how to keep retention high in long–term research on addiction with close assessment — intervals, using biweekly SMS monitoring and quarterly assessments
24.09.2015 Paper Session 21 Frontiers: community perspectives Tomáš Zábranský, Czech Republic Giovanni Aresi, Italy Drinking, drug use and related consequences among university students completing study abroad experiences: A systematic review
24.09.2015 Paper Session 21 Frontiers: community perspectives Tomáš Zábranský, Czech Republic Martine Stead, United Kingdom Just harmless fun? A detailed analysis of the textual, design and graphics features used by online bingo websites to attract new users and encourage heavier  involvement by existing users
24.09.2015 Paper Session 21 Frontiers: community perspectives Tomáš Zábranský, Czech Republic Ximene Rego, Portugal Ethnographic contribution for comprehending outreach work: articulating quantitative data gathered over 12 years of intervention with biographic narratives of illegal drugs users in CTP
24.09.2015 Paper Session 21 Frontiers: community perspectives Tomáš Zábranský, Czech Republic Matej Kosir, Slovenia Engagement of youth organisations in prevention interventions in the field of alcohol policy
24.09.2015 Paper Session 21 Frontiers: community perspectives Tomáš Zábranský, Czech Republic Elizabeth Whittaker, Australia Home sweet home: a longitudinal, mixed methods evaluation of two Housing First programmes for individuals with homelessness and substance use histories in Sydney, Australia
24.09.2015 Symposium session H The European Drug Emergencies Network
(Euro-DEN): insights into acute drug emergencies in Europe
Isabelle Giraudon, EMCDDA Paul Dargan, United Kingdom General overview of the Euro-DEN dataset: 5529 Emergency room presentations with acute drug toxicity over one year in 16 sentinel centres in Europe
24.09.2015 Symposium session H The European Drug Emergencies Network
(Euro-DEN): insights into acute drug emergencies in Europe
Isabelle Giraudon, EMCDDA David Wood, United Kingdom New Psychoactive Substances (NPS) in Euro-DEN: epidemiology and patterns of toxicity associated with NPS
24.09.2015 Symposium session H The European Drug Emergencies Network
(Euro-DEN): insights into acute drug emergencies in Europe
Isabelle Giraudon, EMCDDA Alison Dines, United Kingdom Cannabis presentations in Euro-DEN: An overview of the Euro-DEN data on cannabis-related presentations and cannabis cardiotoxicity
24.09.2015 Symposium session H The European Drug Emergencies Network
(Euro-DEN): insights into acute drug emergencies in Europe
Isabelle Giraudon, EMCDDA Christopher Yates, Spain Implications of benzodiazepines: geographical patterns in the benzodiazepines responsible for toxicity around Europe and the pattern of toxicity seen in individuals with acute benzodiazepine toxicity resulting from non-medical misuse
24.09.2015 Symposium session H The European Drug Emergencies Network
(Euro-DEN): insights into acute drug emergencies in Europe
Isabelle Giraudon, EMCDDA Marcis Trapencieris, Latvia Emergency health consequences of cannabis use in Europe: a need for more unified approach in data collection?
24.09.2015 Symposium session I ISAJE symposium: publishing addiction science: scientific integrity and publication opportunities Kerstin Stenius, Finland Richard Pates, United Kingdom and Michal Miovsky,
Czech Republic
Scientific integrity and publication ethics in the addiction field: the role of the International Society of Addiction Journal Editors
24.09.2015 Symposium session I ISAJE symposium: publishing addiction science: scientific integrity and publication opportunities Kerstin Stenius, Finland Kerstin Stenius, Finland How and where to publish: publication opportunities in addiction science
24.09.2015 Symposium session I ISAJE symposium: publishing addiction science: scientific integrity and publication opportunities Kerstin Stenius, Finland Michal Miovsky, Czech Republic and Richard Pates, United Kingdom The growth of education and training activities in addiction science
24.09.2015 Symposium session I ISAJE symposium: publishing addiction science: scientific integrity and publication opportunities Kerstin Stenius, Finland Thomas Babor, USA Scientific fraud, conflict of interest and lesser evils: the need for ethicality in addiction science
Day 3 (25.09.2015) presentatations
Day Type of session Title of session Chair Name of presenter Title of presentation
25.09.2015 Plenary session 4 Challenges of addiction in an interconnected world Brice De Ruyver, Belgium Anne Line Bretteville-Jensen, Norway Nightclubs — an underused setting for drug prevention?
25.09.2015 Plenary session 4 Challenges of addiction in an interconnected world Brice De Ruyver, Belgium Hein De Vries, The Netherlands Effects of and challenges for computer tailored eHealth programmes
25.09.2015 Plenary session 4 Challenges of addiction in an interconnected world Brice De Ruyver, Belgium Peter Anderson, United Kingdom and Toni Gual, Spain ALICE RAP and the redesign of addictions governance
25.09.2015 Paper session 22 Challenges: new developments in New Psychoactive Substances Floriana Sipala, European Commission Roumen Sedefov, EMCDDA New Psychoactive Substances in Europe — diversity and harms
25.09.2015 Paper session 22 Challenges: new developments in New Psychoactive Substances Floriana Sipala, European Commission Rachel Sutherland presented by Raimondo Bruno, Australia The use of New Psychoactive Substances in Australia: a cross sectional survey of regular psychostimulant users, 2010-2014
25.09.2015 Paper session 22 Challenges: new developments in New Psychoactive Substances Floriana Sipala, European Commission Chris Wilkins, New Zealand Do police arrestees substitute legal highs for alcohol and other drugs?
25.09.2015 Paper session 22 Challenges: new developments in New Psychoactive Substances Floriana Sipala, European Commission Artur Malczewski, Poland What works and what does not work in measures against NPS? Similarities and differences in changing NPS market brought by new regulatory approaches in Eastern and Central European States
25.09.2015 Paper session 22 Challenges: new developments in New Psychoactive Substances Floriana Sipala, European Commission Matthew Young, Canada Detecting a signal in the noise: results of a pilot project to monitor the global spread of new drugs by monitoring media
25.09.2015 Paper session 23 Challenges: constructing addiction: semantics, ideology and evidence Michal Miovsky, Czech Republic François Beck, France French drug policy since the late 90s: from illegal drugs to psychoactive substances, a semantic revolution
25.09.2015 Paper session 23 Challenges: constructing addiction: semantics, ideology and evidence Michal Miovsky, Czech Republic David Miller, United Kingdom Multiple corporate voices in addictions policy — a comparative analysis of industry channels of ‘voice’
25.09.2015 Paper session 23 Challenges: constructing addiction: semantics, ideology and evidence Michal Miovsky, Czech Republic Börje Olsson, Sweden Science, evidence and knowledge for policy and public actions — challenges for individualised, heterogeneous, fluid and accelerating societies
25.09.2015 Paper session 23 Challenges: constructing addiction: semantics, ideology and evidence Michal Miovsky, Czech Republic Ansis Petersons, Latvia Ideological evolution of alcohol policy in Latvia since the restoration of independence: analysis of parliamentary debates
25.09.2015 Paper session 23 Challenges: constructing addiction: semantics, ideology and evidence Michal Miovsky, Czech Republic Willem Scholten, The Netherlands Are the substance lists of the international drug conventions legitimate?
 25.09.2015 Paper session 24  Perspectives on addictions: a focus on youth Maria Renström, WHO Geir Brunborg, Norway Trajectories of heavy drinking from adolescence to early adulthood: predictors of trajectory membership and differences in problematic drinking in early adulthood
 25.09.2015 Paper session 24  Perspectives on addictions: a focus on youth Maria Renström, WHO Jeroen Lammers, The Netherlands Effectiveness of a selective intervention programme targeting personality risk factors for alcohol misuse among young adolescents: results of a cluster randomised controlled trial
25.09.2015 Paper session 24 Perspectives on addictions: a focus on youth Maria Renström, WHO Georgie MacArthur, presented by Matthew Hickman, United Kingdom Peer-led interventions to prevent tobacco, alcohol and/or cannabis use among young people aged 11-21 years: a systematic review and meta-analysis
25.09.2015 Paper session 24 Perspectives on addictions: a focus on youth Maria Renström, WHO Stanislas Spilka, France The alcohol pattern among 17-year-old French teenagers from 2005 to 2014 or how to better assess heavy episodic drinking
25.09.2015 Paper session 24 Perspectives on addictions: a focus on youth Maria Renström, WHO Annie Melaugh McAteer, United Kingdom Alcohol attention bias in school age and undergraduate adolescent social drinkers
25.09.2015 Paper session 25 Challenges: a changing drug market
 
Dirk Korf, The Netherlands Jane Mounteney, EMCDDA A game changer? Results from the EMCDDA study on the Internet and drug markets
25.09.2015 Paper session 25 Challenges: a changing drug market Dirk Korf, The Netherlands Alberto Oteo Pérez, The Netherlands Buying and selling crack: transactions at the retail level and the role of user-sellers
25.09.2015 Paper session 25 Challenges: a changing drug market Dirk Korf, The Netherlands Marina Tzvetkova, United Kingdom Drug dealers’ responses to a changing environment in Italy, Slovenia and Germany
25.09.2015 Paper session 25 Challenges: a changing drug market Dirk Korf, The Netherlands David Otiashvili, Georgia Policing, random street drug testing and poly-substance use chaos in Georgia — a policy case study
25.09.2015 Paper session 25 Challenges: a changing drug market Dirk Korf, The Netherlands Magali Martinez, France Estimating and monitoring NPS popularity on drugs users’ forums: methodological issues and challenges for the researchers
25.09.2015 Symposium session J Digital health interventions for substance use treatment Johannes Thrul, USA Elizabeth Edwards, United Kingdom Cigbreak, a novel smartphone game for smoking cessation
25.09.2015 Symposium session J Digital health interventions for substance use treatment Johannes Thrul, USA Michael Schaub, Switzerland Can Reduce — a chat-counselling and web-based self-help intervention for cannabis users
25.09.2015 Symposium session J Digital health interventions for substance use treatment Johannes Thrul, USA Johannes Thrul, USA Feasibility trial of a Facebook quit smoking intervention with 79 young adult participants
25.09.2015 Symposium session J Digital health interventions for substance use treatment Johannes Thrul, USA Svering Haug, Switzerland A fully automated intervention for smoking cessation that simultaneously addresses alcohol use
25.09.2015 Symposium session K Addressing vulnerabilities, increasing access to services: how to mainstream gender into policy and practice of substance use prevention treatment and rehabilitation Alessandra Liquori O’Neill, UNICRI and Fátima Trigueiros, Portugal Marica Ferri, EMCDDA Addressing gender inequalities in accessing drug addiction services in Europe: challenges and good practices
25.09.2015 Symposium session K Addressing vulnerabilities, increasing access to services: how to mainstream gender into policy and practice of substance use prevention treatment and rehabilitation Alessandra Liquori O’Neill, UNICRI and Fátima Trigueiros, Portugal Giovanna Campello, UNODC Guidelines on drug prevention and treatment for girls and women
25.09.2015 Symposium session K Addressing vulnerabilities, increasing access to services: how to mainstream gender into policy and practice of substance use prevention treatment and rehabilitation Alessandra Liquori O’Neill, UNICRI and Fátima Trigueiros, Portugal Marilyn Clark, Council of Europe Prescription drugs misuse: a global health challenge affecting women and girls
25.09.2015 Symposium session K Addressing vulnerabilities, increasing access to services: how to mainstream gender into policy and practice of substance use prevention treatment and rehabilitation Alessandra Liquori O’Neill, UNICRI and Fátima Trigueiros, Portugal Meni Malliori, Greece Addressing gender based mental health vulnerabilities
25.09.2015 Symposium session L E-health and addictions: virtual interventions in a virtual
reality for real life substance-related problems
Alessandro Pirona, EMCDDA and Cinthia Menel-Lemos, CHAFEA Joran Lokkerbol, The Netherlands Cost-effectiveness of e-health interventions for substance use disorders: modelling the cost-effectiveness of health care systems for alcohol use disorders — how implementation of eHealth interventions improves cost-effectiveness
25.09.2015 Symposium session L E-health and addictions: virtual interventions in a virtual
reality for real life substance-related problems
Alessandro Pirona, EMCDDA and Cinthia Menel-Lemos, CHAFEA Harveen Ubhi, United Kingdom Managing addictions via mobile applications: a smartphone app to aid smoking cessation — preliminary evaluation of SF28 and characterising smoking cessation smartphone apps in terms of behaviour change techniques
25.09.2015 Symposium session L E-health and addictions: virtual interventions in a virtual
reality for real life substance-related problems
Alessandro Pirona, EMCDDA and Cinthia Menel-Lemos, CHAFEA Pjer Vriens, The Netherlands Outreach and harm reduction via online platforms and mobile apps: the Social Intervention Tool, an advanced chat tool for internet-based outreach for drug users, sex workers, MSM and young people at risk
25.09.2015 Symposium session L E-health and addictions: virtual interventions in a virtual
reality for real life substance-related problems
Alessandro Pirona, EMCDDA and Cinthia Menel-Lemos, CHAFEA Jan Copeland, Australia Managing addictions via mobile applications: a smartphone app to assist management of cannabis use
25.09.2015 Symposium session M  From ALICE RAP to UNGASS Peter Anderson, United Kingdom Franz Trautmann, The Netherlands From the EU to UNGASS
25.09.2015 Symposium session M From ALICE RAP to UNGASS Peter Anderson, United Kingdom Toni Gual, Spain Well-being frame to reduce the perverse consequences of drug policies
25.09.2015 Symposium session M From ALICE RAP to UNGASS Peter Anderson, United Kingdom Dirk Lachenmeier, Germany Toxicology as a basis for rational policy
25.09.2015 Symposium session M From ALICE RAP to UNGASS Peter Anderson, United Kingdom Tamyko Ysa, Spain Trendsetters in drug policy
e-posters
Day Poster code Title of poster Name of presenter
23.09.2015 I.1 Cross-level interactions between individual drinking motives and the number of friends present in the drinking situation predict alcohol consumption over the course of the evening Johannes Thrul, USA
23.09.2015 I.3 Who are the hazardous drinkers? Results from the 2012 General Population Survey. Clara Vital, Portugal
23.09.2015 I.4 Decriminalisation — a preventive and health promotion approach Alcina Ló, Portugal
23.09.2015 I.5 Substance use disinhibition associated with economically rational decision to quit a boring task Torleif Halkjelsvik, Norway
23.09.2015 I.6 Understanding study abroad students’ drinking and drug taking behaviour: a qualitative study Giovanni Aresi, Italy
23.09.2015 I.7 Ten years of ‘Addictology’ — complex university education for addiction specialists in the Czech Republic Amalie Pavlovska, Czech Republic
23.09.2015 I.8 Smoking habits of Naval School students: is the military environment a risk for tobacco initiation? Ana Pratas, Portugal
23.09.2015 I.9 Safety and health in the workplace and psychoactive substances use: guidelines for workplace intervention Natacha Torres da Silva, Portugal
23.09.2015 I.10 Statistical analysis of the social determinants of problematic alcohol consumption at advanced ages in Europe Mara Silva, Portugal
23.09.2015 I.11 Comparison between non-general practice patients and general practice patients treated for substance use problems Jérôme Antoine, Belgium
23.09.2015 I.12 Living conditions, quality of life and wellbeing among clients in opioid substitution treatment (OST) in four European countries: Spain (Catalonia), Sweden,
The Netherlands and Poland
Joan Colom, Spain
23.09.2015 I.13 Persistent sleep problems and addiction: the Stayer study Sverre Nesvåg, Norway
23.09.2015 I.14 Parenting styles and drug use among Estonian 15- to 16-year-old students based on ESPAD data Sigrid Vorobjov, Estonia
23.09.2015 I.15 Epidemiological survey on the prevalence of problem gambling in the adult population in Greece Meni Malliori, Greece
23.09.2015 I.16 The process of social reintegration in men and women addicted to substances in rehabilitation: an analysis from a gender perspective Ricardo Sánchez Huesca, Mexico
23.09.2015 I.18 Assessment tools in substance use treatment – useful for patient and clinician? Janne Årstad, Norway
23.09.2015 I.19 Factors influencing changes in alcohol consumption among working-age Russian men: qualitative study exploring the role of social context, the workplace and perceptions
of appropriate behaviour
Katherine Keenan, United Kingdom
23.09.2015 I.20 Work-related drinking and processes of social integration and marginalisation in two Norwegian workplaces Sverre Nesvåg, Norway
23.09.2015 I.21 Adolescent substance use: results from an universal school-based programme Ana Tavares, Portugal
23.09.2015 I.22 TAKE CARE: multi-levels approach to reduce alcohol consumption in juvenile groups Maria do Rosário Mendes, Portugal
23.09.2015 I.23 Referral/articulation network in the field of addictive behaviours and dependencies — An inter-institutional integrated and differentiated articulation of care Sofia Borges Pereira, Portugal
23.09.2015 I.24 Staff smoking in substance misuse services: a qualitative study Maria Duaso, United Kingdom
23.09.2015 II.1 Changing attitudes in occupational health professionals with specialised training in alcohol screening and brief interventions as a strategy for addressing alcohol-related problems in the workplace Jorge Barroso Dias, Portugal
23.09.2015 II.2 Use of contingency management treatment to reduce crack use and promote crack abstinence in Brazil. Results from a randomised clinical trial André de Queiroz, Brazil
23.09.2015 II.3 Are DSM-5 pharmaceutical opioid use disorder continua consistent across chronic pain and injecting drug use populations? Raimondo Bruno, Australia
23.09.2015 II.4 Cigarette filters: low-cost and effective harm reduction for removing particulate contamination from injections derived from pharmaceutical tablets Rahul Patel presented
by Raimondo Bruno, Australia
23.09.2015 II.5 Incidence of hepatitis C in a European low threshold methadone programme Mário Jorge Silva, Portugal
23.09.2015 II.6 HBSC and ESPAD in France: a marriage of convenience, but not only! Spilka Stanislas, France
23.09.2015 II.7 The neglected impact of nicotine addiction in understanding cannabis dependence among European cannabis smokers Alessandro Pirona, EMCDDA
23.09.2015 II.9 What is new on ecstasy in France? Shapes, rates and user perceptions Thomas Nefau, France
23.09.2015 II.10 Sociological profiles of the use of and dependency on psychoactive substances among workers (Portuguese GPS 2012 data) Claudia Urbano, Portugal
23.09.2015 II.11 Use and misuse of prescription drugs among French drug users Agnès Cadet-Tairou, France
23.09.2015 II.12 The association among behavioural addictions, illegal drug use and eating disorders in the general population: how relevant is age? Valeria Siciliano, Italy
23.09.2015 II.13 Spread it” A response to the HIV epidemic in Athens using the “Boule de Neige” technique: new alarming evidence concerning active drug users Litsa Lagakos, Greece
23.09.2015 II.14 Financing health and drug policy in Europe in the wake of the 2008-2009 recession: an economic analysis Cláudia Costa Storti, EMCDDA
23.09.2015 II.15 The effects of regular cannabis use during adolescence Rita Notarandrea, Canada
23.09.2015 II.16 Medical cannabis and cannabinoids: promise for general public health, threat for addictions field? Tomáš Zábranský, Czech Republic
23.09.2015 II.17 Blood borne diseases in the Czech prisons: disarming a ticking timebomb needs devoted exerts, now! Tomáš Zábranský, Czech Republic
23.09.2015 II.18 Development, selection and validation of quality indicators of care following intensive rehabilitation for alcohol dependence: a Delphi study Dieter Zeeuws, Belgium
23.09.2015 II.19 Methodological dilemmas related to the drug use prevalence estimates in the context of an adult population opinion survey Borbála Paksi presented by Katalin Felvinczi, Hungary
23.09.2015 II.20 Bottom-up processes in governance. A case study of the knowledge base for redesigning governance Hildegunn Sagvaag, Norway
23.09.2015 II.21 Analysis of risk factors/determinants of overdose Isabel Ponte, Portugal
23.09.2015 II.22 Cannabidiol (CBD) for the management of cannabis withdrawal: a phase II proof of concept study Jan Copeland, Australia
23.09.2015 II.24 A general population study of adolescents’ exposure to cannabis use offers Jasmina Burdzovic Andreas, Norway
24.09.2015 III.1 The role of individual and social capital on cocaine addiction recovery Anne Dekkers, Belgium
24.09.2015 III.2 CRAFFT validation study in a Spanish sample: psychometric properties and recommendations Manuel Araujo Gallego, Spain
24.09.2015 III.3 Systemically-focused substance abuse prevention strategies from India's addiction treatment professionals: results from a national survey using a mixed-method research design Sebastian A. Perumbilly, USA
24.09.2015 III.4 Executive functions as predictor of substance use disorder and social adjustment: a sequential logistic regression approach. Preliminary results Egon Hagen, Norway
24.09.2015 III.5 Mitochondrial energy activity failure in drug addiction — preliminary study Cândida Mendes presented by Manuela Grazina, Portugal
24.09.2015 III.6 Drug-related deaths (DRAMES survey): focus on the Languedoc-Roussillon region Céline Eiden, France
24.09.2015 III.7 Epidemiologic profile of users assisted in a psychosocial care centre for type III adults Paula Silva, Brazil
24.09.2015 III.8 Translating knowledge for better practices in psychological prevention and treatment in alcohol-related problems Ana Nunes da Silva, Portugal
24.09.2015 III.9 Mapping drug users: the example of the Emilia Romagna region Stefano Salvadori, Italy
24.09.2015 III.10 The use of suboxone (buprenorphine and naloxone) in prison Fadi Meroueh, France
24.09.2015 III.11 The Operational Plan for Integrated Responses is a structural measure implemented at national level that promotes accurate assessments and the development of
integrated interventions at local level
Madalena Cruchinho presented by Paula Frango, Portugal
24.09.2015 III.12  Do guidelines for alcohol and drug treatment capture what comprehensive theories on understanding addiction tell us is important in treatment? A review of five
guidelines
Espen Andreas Enoksen, Norway
24.09.2015 III.13 Room for action? How service managers in three Scandinavian cities experience their possibilities to develop their services Ole Næss, Norway
24.09.2015 III.14 Injection-related disorders among Moscow street drug users Sofia Fedorova, Russia
24.09.2015 III.15 Before you get burned: seven years of peer counselling and harm reduction in university students' festivals Irma Brito, Portugal
24.09.2015 III.16 Innovation and social reintegration: evaluation of a new form of governance in public action for the social rehabilitation of drug addicts François Vedelago, France
24.09.2015 III.17 City level drug policies in Europe — a documentary analysis Eoghan Quigley, EMCDDA
24.09.2015 III.18 Understanding and evaluating effective interventions for prevention of adolescent substance use: what we know from research and what we can transfer into practice Roberta Molinar, Italy
24.09.2015 III.19 Ageing and addiction: are European addiction treatment systems ready for the challenges ahead? Alessandro Pirona, EMCDDA
24.09.2015 III.20 Supervised consumption services: the Greek experience Meni Malliori, Greece
24.09.2015 III.21 Alcohol use in Galician secondary school population (Spain): current data and related variables Patricia Gómez, Spain
24.09.2015 III.22 Adjustment of buprenorphine/naloxone dose desired by heroin-dependent patients: comparison of non-modifiers, raisers and reducers  José Pérez de los Cobos, Spain
24.09.2015 III.23 URICA maintenance subscale and frequency of recent cocaine use independently predict cocaine-positive baseline urine at inpatient detoxification treatment José Pérez de los Cobos, Spain
24.09.2015 III.24 Guidelines for Social and Community Mediation in the field of reintegration of people with addictive behaviours and dependencies Sara Carvalho, Portugal
24.09.2015 III.25 Characterisation of CYP2D6 genotypes in drug addicts — a preliminary study Carolina Ribeiro presented by Manuela Grazina, Portugal
24.09.2015  IV.1 Addiction, families and treatment. A critical realist search for theories that can improve practice  Anne Schanche Selbekk, Norway
24.09.2015 IV.2 Methylphenidate substitution for methamphetamine addiction: a unique case series Roman Gabrhelík, Czech Republic
24.09.2015 IV.3 ‘I have no clue what I drunk last night’. Using smartphone technology to compare in-vivo and retrospective self-reports of alcohol consumption Roberta Monk, presented by Derek Heim, United Kingdom
24.09.2015 IV.4 Estimating the number of problem drug users with mortality data when drug-related deaths are under-reported: a case study Eric Janssen, France
24.09.2015 IV.5 Early intervention for adolescent substance use and abuse in Switzerland: The DEPART program Nicolas Meylan, Switzerland
24.09.2015 IV.8 Ethics of addiction research: conceptual critique of the drug-centred view Susanne Uusitalo, Finland
24.09.2015 IV.9 Drinking patterns and alcohol use disorder characteristics in senior citizens with DSM-5 alcohol use disorder entering an outpatient short-term intervention: results from a randomised clinical trial Silke Behrendt, Germany
24.09.2015 IV.10 High risk drug users: ESPAD, therapeutic communities and harm reduction services surveys and data analyses to understand various aspects of the lifestyle and risk
behaviour
Luca di Censi, Italy
24.09.2015 IV.11 Think tanks and addictions in the EU — a network study David Miller, United Kingdom
24.09.2015 IV.12 The use and misuse of sodium oxybate in Italian alcohol dependent patients: results from the GUM study Felice Nava, Italy
24.09.2015 IV.13 Pharmaceuticalisation of drug cultures: qualitative study on polydrug use and user networks on the Internet Sanna Rönkä, Finland
24.09.2015 IV.14 Social resources and their association with outcomes of alcohol treatment in different age groups. A literature review Anne Kohlmann, Germany
24.09.2015 IV.15 Crisis intervention related to the use of psychoactive substances in recreational settings — evaluating the Kosmicare Project at Boom Festival Paula Frango, Portugal
24.09.2015 IV.16 Gender differences among current Internet gamers — results from an Internet based survey in Singapore  Pratika Satghare, Singapore
24.09.2015 IV.17  A comparison between sewage-based epidemiology and epidemiological research on drug use in the general population Janelle van Wel, Belgium
24.09.2015 IV.18 Trajectories of alcohol consumption and association with symptoms of depression from early to late adolescence. The Norwegian Longitudinal Health Behaviour Study Jens Christoffer Skogen, Norway
24.09.2015 IV.20 Effectiveness of video enabled relapse prevention intervention (VERPI) among alcohol dependent individuals: a prospective study at central and state government mental health settings in India Prasanthi Nattala, India
24.09.2015 IV.21 Social media addiction was influenced by quality family time among adolescents in Bangkok Metropolitan Asara Vasupanrajit, Thailand
24.09.2015 IV.22 Identifying research priorities for illicit drugs in Europe Charlotte Davies, United Kingdom
24.09.2015 IV.24 Ketamine: medical indications, recreational use and abuse liability Cécile Chevallier, France
25.09.2015 V.1 Translation and adaptation of the game addiction scale in an adolescent sample: Portuguese version Nidia Rosa, Portugal
25.09.2015 V.2 High biological-based HCV incidence and increasing frequency of high-risk practices among IDUs in France: what are the implications for harm reduction models? Marie Jauffret-Roustide, France
25.09.2015 V.3 Drug trends between 1994 and 2014 in Hungary — expansion of designer drugs Eva Keller, Hungary
25.09.2015 V.4 Factors predicting speed of transition to opportunity to use cannabis, and from opportunity to cannabis dependence Lindsey A. Hines, United Kingdom
25.09.2015 V.5 Comparing alcohol use between migrants and non-migrants in Germany: who might be at risk and why? An epidemiological study Elena Gomes de Matos, Germany
25.09.2015 V.6 Alcohol, crack/cocaine and violence in Brazil: data from the Brazilian National Alcohol and Drugs Survey (BNADS 2006/2012) Clarice Sandi Madruga, Brazil
25.09.2015 V.7 Crackland in Brazil, a failed experience of legalisation and attempts to build up a network of assistance Clarice Sandi Madruga, Brazil
25.09.2015 V.8 Problematic Internet use in Malta amongst young people aged between 18–30 years: a quantitative study Anna Maria Vella, Malta
25.09.2015 V.9 Elicitation research for the construction of a prevention programme of alcohol-related problems Raúl Melo, Portugal
25.09.2015 V.10 Local community and school setting as the place for implementation of prevention in Central Asia Boguslawa Bukowska, Poland
25.09.2015 V.11  Problematic Internet use (PIU) in Portuguese adolescents: an exploratory study of wellbeing outcomes Ivone Patrão, Portugal
25.09.2015 V.12

A successful strategy for linking anonymous data of children and parents in a school-based trial

Roman Gabrhelík, Czech Republic
25.09.2015 V.13 Tracking NPS: Nuclear Magnetic Resonance (NMR) for a rapid identification of new substances Helena Gaspar, Portugal
25.09.2015 V.14 New Psychoactive Substances in Europe Roumen Sedefov, EMCDDA
25.09.2015 V.15 How do the four Ps of marketing contribute to initiation, risky use and harmful use of alcohol, tobacco and gambling? A synthesis of evidence Martine Stead, United Kingdom
25.09.2015 V.16 Recent developments in detection of harms arising from the use of synthetic cannabinoid receptor agonists in Europe Andrew Cunningham, EMCDDA
25.09.2015 V.17 New Psychoactive Substances in Europe: New Psychoactive Substances among people using drugs heavily - Towards effective and comprehensive health responses
in Europe
Cristiana Vale Pires, Portugal
25.09.2015 V.18 Cannabis-related indicators: up or down? Good or bad? What do the data tell us? João Matias, EMCDDA
25.09.2015 V.19 Offline and online characterisation of Portuguese pathological gamblers: results Pedro Hubert, Portugal
25.09.2015 V.20 The experience of the use of psychedelic substances Joana M. N. Pereira, Portugal
25.09.2015 V.21 Harm reduction and HIV/HCV responses for several populations. The challenge of integrating responses Ricardo Fuertes, Portugal
25.09.2015 V.22 Cannabis and psychosis: What kind of link? Mohamed Ben Amar, Canada
25.09.2015 V.23 Screening of problematic Internet use in adolescents from Galicia (Spain): current data and related variables  Patricia Gómez, Spain
25.09.2015 V.24 Education and specialization of addiction professionals in the Czech Republic in comparison to other European countries (systematic review)  Michal Miovsky, Czech Republic
25.09.2015  V.25 Coping with stress and personality hardiness of clients with and without ADHD in therapeutic communities in the Czech Republic Lenka Cablova, Czech Republic
25.09.2015 V.26 Risk of HCV infection among heroin and methamphetamine users Lubomir Okruhlica, Slovakia
25.09.2015 V.28 Emergency health consequences of cannabis use in Europe: a need for more unified approach in data collection? Marcis Trapencieris, Latvia
25.09.2015 V.29 Old dog, new tricks? Making use of opiate supply and markets information for horizon scanning Nicola Singleton, EMCDDA
25.09.2015 V.30 Prevention and Policy foresight 2025 — a Delphi expert panel study on efficacy Katariina Warpenius, Finland
25.09.2015 V.31 The austerity measures and the Portuguese model of drug policy: an exploratory mixed method research Maria João Oliveira, Portugal
25.09.2015 V.32 Parachuting psychoactives substances: a sustained-release form? Amélie Daveluy, France
25.09.2015 V.33 Shaken, not stirred: what are consumers taking with their cocaine dose Ana Matias, Portugal
25.09.2015 V.34 Comparison of Paper-and-Pencil versus Web Administration on self-reports of sensitive and non-sensitive behaviors among students: participation, data quality and
prevalence estimates
Sabrina Molinaro, Italy
25.09.2015 V.35 Regional drug strategies across the world Danilo Ballotta, EMCDDA
25.09.2015 V.36 European guidelines for the evaluation of national drug strategies and action plans Charlotte Colman, Belgium
25.09.2015 V.37 Problematic Facebook use: the role of psychosocial variables in an italian adolescents study Valerio Salvati, Italy

  Back to top of table  

 

Press Release

Download press release as PDF: English | Portuguese

Download press release as Word document: English | Portuguese

Leading experts to review global developments in addiction science at pioneering European conference

(17.09.2015, LISBON) Leading European and international experts in the field of addiction science will meet in Lisbon from 23-25 September for the First European conference on addictive behaviours and dependencies (1). Showcasing the latest developments in addiction science, the conference will explore the topics of illicit drugs, alcohol, tobacco, gambling and other addictive behaviours. The event is hosted and steered by the Portuguese General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), in collaboration with: the scientific journal Addiction; the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the International Society of Addiction Journal Editors (ISAJE).

The pioneering conference, which has reached its maximum capacity of 600 participants, is designed to appeal to a multidisciplinary audience. It will draw on expertise from a variety of fields including: epidemiology, policy and clinical research, social sciences and human psychopharmacology.

The conference, taking place at the Feira Internacional de Lisboa (Parque das Nações), is organised around four themes:

  • Addictions: a multidisciplinary perspective
  • Translating research into policy and practice
  • New frontiers in addiction research
  • Challenges of addiction in an interconnected world

The packed programme includes: 16 keynote speeches; some 200 oral presentations; around 140 rapid communications and a week-long array of satellite meetings, side-events and sponsored sessions. Among the side-events will be: an EMCDDA technical conference commemorating ‘20 years of monitoring and communicating evidence on drugs’ (21-22 September, EMCDDA) and the 2015 EMCDDA scientific paper award (23 September, FIL). The three collaborative partners (2) will also hold meetings: the ALICE-RAP symposium (22 September, FIL); the ERANID research call event (22 September, FIL); and the Management Board and Advisory Board meetings of the Joint Action on Reducing Alcohol Related Harm (RARHA) project (21 September, SICAD).

The conference, which gathers experts from 58 countries, will provide a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines and address new challenges and developing fields. Prominent partners, including international and national organisations and European research projects, will contribute to the scientific excellence of the event.

The opening and closing sessions are open to the media:

  • Opening session: 23 September — 10:00–10:30 — Auditorium I
  • Closing session: 25 September — 12:30–13:00 — Auditorium I

(1) Full programme and details of side-events are now available at www.lisbonaddictions.eu
(2) For more, see
www.lisbonaddictions.eu/start#sponsors
Contact: Paula Vale de Andrade, SICAD comunicacao@sicad.min-saude.pt

Get ready

 

Venue

  • FIL Meeting Centre - Parque das Nações
  • Address: Rua do Bojador - Parque das Nações | 1998-010 Lisbon – Portugal (GPS 38.769446, -9.092897)
  • Seven minutes by taxi from Lisbon Airport
  • Two-minute stroll from the Oriente metro station

Lisbon | Portugal

  • Visit Lisbon | Visit Portugal
  • Accomodations | Food
  • Weather: due to the influence of the Atlantic Ocean, Lisbon has a pleasant climate throughout the year and nearly constant sunshine
  • Time Zone: GMT/UTC (+1 in Summer)
  • Calls (country code for Portugal): + 351
  • Currency: The unit of currency in Portugal is the Euro €
  • Electricity: Voltage 220/380 volts at a frequency of 50 Hertz. All sockets follow European standards. To use American-type plugs, a 220-volt transformer should be used together with an adapter plug.

#Lxaddictions15

  • Conference language: English
  • Conference dinner: Thursday 24 September at 20.00. Pre-booking is required (more details available soon).
  • Internet: Wi-fi available at the lobby area of the Meeting Centre

More practical information

  • Visa letter: please contact us
  • Religion: although Catholicism predominates, all other major religions have well-established communities in Portugal and particularly in Lisbon. For the participants wishing to celebrate Yom Kippur, please see information on religious services and the contact details of the Lisbon Synagogue
  • Conference newsletter (archive)
  • Conference privacy statement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Registration closed

Due to the high level of interest in this conference, we have already reached maximum capacity.

Organisers and partners

With the support of

 

Programme Committee

  • Manuel Cardoso (SICAD)
  • Ana Sofia Santos (SICAD)
  • Robert West (Addiction)
  • John Marsden (Addiction)
  • Ann McNeill (Addiction)
  • Paul Griffiths (EMCDDA)
  • Julian Vicente (EMCDDA)
  • Maria Moreira (EMCDDA)
  • Liesbeth Vandam (EMCDDA)
  • Richard Pates (ISAJE)
  • Michal Miovsky (ISAJE)
  • Catherine Moury (Universidade Nova de Lisboa)

Conference secretariat

  • Mónica Baptista (SICAD)
  • Ana Castro (SICAD)
  • Renate Hochwieser (EMCDDA)
  • Alberto Oteo (EMCDDA)
  • Agata Rybarska (EMCDDA)

Technical support group

  • Maria José Ribeiro (SICAD)
  • Filipa Cunha (SICAD)
  • Marie-Christine Ashby (EMCDDA)
  • Andrea Claessen (EMCDDA)
  • Cécile Martel (EMCDDA)
  • Klaudia Palczak (EMCDDA)
  • David Penny (EMCDDA)
  • Silke Vitt (EMCDDA)

Scientific Committee

  • Judith Aldridge (Senior Lecturer, School of Law, University of Manchester, UK)
  • Hannu Alho (ISAM  President, Professor of Addiction Medicine, Finland)
  • Sevil Atasoy (Professor, former president International Narcotics Control Board (INCB) and Vice-Rector of Uskudar University, Istanbul, Turkey)
  • Henri Bergeron (Chair in Health Studies, Sciences Po Paris, France)
  • Kim Bloomfield (Professor, Center for Alcohol and Drug Research, Aarhus University, Denmark)
  • Anne Line Bretteville-Jensen (Research Director, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway)
  • Angelina Brotherhood (Public Health Researcher, Liverpool John Moores University, UK)
  • Gerhard Bühringer (Chair of Addiction Research, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany)
  • Catherine Comiskey (Head of School of Nursing and Midwifery, Trinity College, Ireland)
  • Ornella Corazza (Reader in Substance Addictions and Behaviours, University of Hertfordshire, Hatfield, UK)
  • Paul Dargan (Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust, and Reader in Toxicology, King’s College London, London, UK)
  • Marina Davoli (Head, Department of Epidemiology, National Agency for Health Services, Italy)
  • Louisa Degenhardt (Professor, National Drug and Alcohol Research Centre (NDARC), Australia)
  • Fernando Rodríguez de Fonseca (Fundación IMABIS, Hosp. Univ. Carlos Haya de Málaga, Spain)
  • Brice de Ruyver (Full Professor criminal law and criminology, Director Institute for International Research on Criminal Policy, Ghent University, Belgium)
  • Fabrizio Faggiano (Professor of Public Health at the Department of Translational Medicine of the University of the Piemonte Orientale, Italy)
  • Michael Farrell (Director, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Australia)
  • Gabriele Fischer (Medical Director of the Addiction Clinic at the Medical University Vienna, Austria)
  • Henk Garretsen (Professor, Director Tranzo, Scientific Centre for Care and Welfare, Tilburg University, The Netherlands)
  • Eilish Gilvarry (President of the Society for the Study of Addiction, Honorary Professor of Addiction Psychiatry, Newcastle University, UK)
  • Wayne Hall (Professor, Director and Inaugural Chair, Centre for Youth Substance Abuse Research, The University of Queensland, Australia)
  • Matthew Hickman (School of Social and Community Medicine, University of Bristol, UK)
  • Keith Humphreys (Professor, Stanford School of Medicine, USA)
  • Kamil Kalina (Associate Professor, Departement of Addictology, Charles University, Czech Republic)
  • Dirk Korf (Professor, Bonger Institute of Criminology, University of Amsterdam, The Netherlands)
  • Krzysztof Krajewski (Chair of Criminology, Jagiellonian University, Poland)
  • Ludwig Kraus (Director, IFT Institut für Therapieforschung, Munich, Germany)
  • Håkan Leifman (Director, Swedish Council for Information on Alcohol and Other Drugs (CAN), Sweden)
  • Henrique Lopes (President of the Ibero-latin-american Scientific Society for Gambling Research, Chair of CEIA research center, researcher at Public Healthcare Unit of Catholic University - ICS)
  • Meni Malliori (Associate Professor of Psychiatry, Medical School, National & Kapodistrian University of Athens, Greece)
  • Olivia Maynard (Associate Teacher, School of Experimental Psychology, University of Bristol, UK)
  • Emília Nunes (Professor, Director of the National Programme for Prevention of Smoking and Tobacco Control, General-Directorate of Health, Portugal)
  • Rebecca McKetin (Associate Professor, ANU College of Medicine, Biology and Environment, Australia)
  • Letizia Paoli (Professor, Leuven Institute of Criminology, University of Leuven, Faculty of Law, Belgium)
  • Jürgen Rehm (Director, Social and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, Toronto, Canada)
  • Xavier Majó i Roca (Office of Drug Addiction, Public Health Agency of Catalonia, Spain)
  • Emanuele Scafato (Director of Population’s Health and Health Determinants Unit in the National Centre for Epidemiology, Surveillance and Health Promotion-CNESPS at the Istituto Superiore di Sanità, Italy)
  • Janusz Sieroslawski (Institute of Psychiatry and Neurology, Poland)
  • Jussi Simpura (Chair, Finnish Foundation for Alcohol Studies)
  • Zili Sloboda (President, Applied Prevention Science, Inc., USA)
  • Rainer Spanagel (Professor of Pharmacology & Toxicology, Head of the Institute of Psychopharmacology, University of Heidelberg, Germany)
  • John Strang (Professor, Head of the Addictions Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, UK)
  • Harry Sumnall (Professor, Centre for Public Health, Liverpool John Moores University, UK)
  • Margriet Van Laar (Head of the Department Drug Monitoring, Trimbos Institute, The Netherlands)
  • Graça Vilar (Director of the Planning and Intervention Department of SICAD, Master in forensic medicine and forensic sciences, Graduate Assistant of Psychiatry Hospital, Portugal)